Quarterly report pursuant to Section 13 or 15(d)

Cash Equivalents and Marketable Securities

v3.22.2
Cash Equivalents and Marketable Securities
6 Months Ended
Jun. 30, 2022
Cash and Cash Equivalents [Abstract]  
Cash Equivalents and Marketable Securities

4. Cash Equivalents and Marketable Securities

Cash equivalents and marketable securities consisted of the following:

 

 

 

June 30, 2022

 

 

 

Amortized
Cost Basis

 

 

Unrealized
Gains

 

 

Unrealized
(Losses)

 

 

Fair
Value

 

 

 

(in thousands)

 

Money market funds

 

$

61,187

 

 

$

-

 

 

$

-

 

 

$

61,187

 

Commercial paper

 

 

23,129

 

 

 

-

 

 

 

-

 

 

 

23,129

 

Corporate debt securities

 

 

32,443

 

 

 

-

 

 

 

(518

)

 

 

31,925

 

Asset-based securities

 

 

8,630

 

 

 

-

 

 

 

(47

)

 

 

8,583

 

U.S. government securities

 

 

37,462

 

 

 

-

 

 

 

(565

)

 

 

36,897

 

U.S. agency securities

 

 

4,992

 

 

 

-

 

 

 

(2

)

 

 

4,990

 

Supranational debt securities

 

 

16,191

 

 

 

-

 

 

 

(224

)

 

 

15,967

 

Total

 

 

184,034

 

 

 

-

 

 

 

(1,356

)

 

 

182,678

 

Less amounts classified as cash equivalents

 

 

(70,167

)

 

 

-

 

 

 

2

 

 

 

(70,165

)

Total marketable securities

 

$

113,867

 

 

$

-

 

 

$

(1,354

)

 

$

112,513

 

 

 

 

December 31, 2021

 

 

 

Amortized
Cost Basis

 

 

Unrealized
Gains

 

 

Unrealized
(Losses)

 

 

Fair
Value

 

 

 

(in thousands)

 

Money market funds

 

$

29,451

 

 

$

-

 

 

$

-

 

 

$

29,451

 

Commercial paper

 

 

22,580

 

 

 

-

 

 

 

-

 

 

 

22,580

 

Corporate debt securities

 

 

75,012

 

 

 

-

 

 

 

(151

)

 

 

74,861

 

Asset-based securities

 

 

32,975

 

 

 

-

 

 

 

(18

)

 

 

32,957

 

U.S. government securities

 

 

47,504

 

 

 

-

 

 

 

(84

)

 

 

47,420

 

Supranational debt securities

 

 

21,361

 

 

 

-

 

 

 

(61

)

 

 

21,300

 

Total

 

 

228,883

 

 

 

-

 

 

 

(314

)

 

 

228,569

 

Less amounts classified as cash equivalents

 

 

(29,451

)

 

 

-

 

 

 

-

 

 

 

(29,451

)

Total marketable securities

 

$

199,432

 

 

$

-

 

 

$

(314

)

 

$

199,118

 

As of June 30, 2022 and December 31, 2021, zero and $68.8 million, respectively, of marketable securities had maturities of more than one year and less than two years and are classified as non-current assets.

There were $98.4 million and $176.5 million of investments in an unrealized loss position of $1.4 million and $0.3 million as of June 30, 2022 and December 31, 2021, respectively. During the three and six months ended June 30, 2022 and 2021, the Company did not record any other-than-temporary impairment charges on its available-for-sale securities. Based on the Company’s procedures under the expected credit loss model, including an assessment of unrealized losses on the portfolio after June 30, 2022 and 2021, the Company concluded that the unrealized losses for its marketable securities were not attributable to credit and therefore an allowance for credit losses for these securities has not been recorded as of June 30, 2022 and 2021. Also, based on the scheduled maturities of the investments, the Company was more likely than not to hold these investments for a period of time sufficient for a recovery of the Company’s cost basis.

The Company recognized no material gains or losses on its cash equivalents and current and non-current marketable securities as of June 30, 2022 and December 31, 2021 and as a result, the Company did not reclassify any amounts out of accumulated other comprehensive loss for the period then ended.